About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 419 record(s)
Req # A-2021-001342
Full copies of all adverse reaction reports with the suspected active ingredient glucagon received by Health Canada between January 1, 2021 and November 10, 2021.Organization: Health Canada
August 2022
Req # A-2021-002007
Copies of the Quality Overall Summary (QOS) for the following products: Palbociclib tablets: Drug Identification Number (DIN) 02493535, DIN 02493543, DIN 02493551.Organization: Health Canada
August 2022
Req # A-2021-002056
The standard applied by Health Canada for determining whether a vaccine is "safe".Organization: Health Canada
August 2022
Req # A-2022-000070
Identify all Health Canada mandated studies of airborne and waterborne hazards at Canadian Security Intelligence Service (CSIS) offices across Canada, the dates these studies were mandated and the results of these findings. The period under review…Organization: Health Canada
August 2022
Req # A-2022-000159
The current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product (Control No. 245431), which was accepted into review by Health Canada on February 26, 2021.Organization: Health Canada
August 2022
Req # A-2022-000160
The Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product (Control No. 245431) received a Notice of Non-Compliance (NON) on August 23, 2021. If the sponsor submitted a Response to the NON: (i) the month and…Organization: Health Canada
August 2022
Req # A-2022-000302
A complete list of all Licensed Medical Doctors employed by Health Canada and Advisors/Consultants to Health Canada. A list of the individuals employed by Health Canada and Advisors/Consultants to Health Canada whose Medical Licenses have been…Organization: Health Canada
August 2022
Req # A-2022-000328
Number of licences issued for cannabis cultivation, by year, for each of the years 2016 to 2021, between August 24, 2016 and June 11, 2022 in Quebec and in each of the other Canadian provinces. The same figures for the beginning of 2022 if available…Organization: Health Canada
August 2022
Req # A-2022-000432
All ventilation and/or building air filtration records from Health Canada's Occupational Health and Safety (OHS) division, from March 1, 2020 to June 30, 2022.Organization: Health Canada
August 2022
Req # A-2022-000462
Contracted studies, internal documents, reports and statistics by Canadian Research Initiative in Substance Misuse (CRISM) regarding addiction treatment and opioid agonist treatment (OAT) and any contribution to policy changes regarding addiction…Organization: Health Canada
August 2022